Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmaceuticals Finland

Pekka Suhonen Department of Pharmaceutics, University of Kuopio, Kuopio, Finland... [Pg.16]

Finland None. A choice is made between a prior annual payment, a co-payment, and a co-payment with a maximum in the user-shared bill for the annual cost. Varies according to the municipality Maximum payment levels for (daily) hospital stays and for specialist visits Percentage rates of user sharing in pharmaceutical costs... [Pg.8]

Vieno N, Tuhkanen T, Kronberg L (2007) Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 41 1001-1012... [Pg.136]

Orla Miller Larsson Department of Pharmacology, The Danish University of Pharmaceutical Sciences, Copenhagen, Denmark Sari E. Lauri Neuroscience Center and Department of Biosciences, University of Helsinki, Helsinki, Finland... [Pg.283]

P. Calvo, J. L. Vila-Jato, and M. J. Alonso, Corneal penetration of 14C-indomethacin-loaded nanocapsules, in Methods to Overcome Biological Barriers in Drug Delivery, Kuopio, Finland, 1993, Kuopio University, Department of Pharmaceutical Technology, p. 93. [Pg.18]

Norplant is a registered trademark of the Population Council, It is manufactured and distributed by Leiras Pharmaceuticals in Finland, under license from the Population Council, It is marketed in the United States by Wyeth-Ayerst Laboratories, Inc, of Philadelphia. [Pg.48]

Conversely, in countries where the population is relatively small and where individual consumption of medicines is low and pharmaceutical industry investment is also low, the government is able to enforce low prices for medicines. These countries are typified by the Netherlands, Norway, Finland and Denmark. Sweden, where there is significant pharmaceutical research, is atypical of the rest of Scandinavia and the medicines price index and medicine consumption are approximately the European average. [Pg.718]

Wehrli, A. 1997. Counterfeited and substandard active pharmaceutical ingredients seminar paper read at PLC/S Seminar held in Naantali, Finland. Pharmaceutical Inspection Convention Scheme. [Pg.453]

Levis A. A. and Papageorgiou L.G. 2003. Multisite capacity planning for the pharmaceutical industry using mathematical programming. Proceedings of the ESCAPE 13 Meeting, Lappeenranta, Finland, 1-4 June 2003. [Pg.373]

Sachin Surwase Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Helsinki, Finland... [Pg.716]

Valo H. Biopolymer-Based Nanoparticles for Drug Debvery. Finland Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki 2012. [Pg.109]

Aho, E. (1953) On the artificial production of ergot in Finland. Farmaseuttinen Aikakaus Lehti (Pharmaceutical Bulletin), 54,115-129. [Pg.317]

See other pages where Pharmaceuticals Finland is mentioned: [Pg.441]    [Pg.584]    [Pg.41]    [Pg.195]    [Pg.195]    [Pg.202]    [Pg.224]    [Pg.33]    [Pg.11]    [Pg.17]    [Pg.110]    [Pg.68]    [Pg.230]    [Pg.341]    [Pg.344]    [Pg.27]    [Pg.28]    [Pg.31]    [Pg.8]    [Pg.173]    [Pg.69]    [Pg.67]    [Pg.136]    [Pg.1721]    [Pg.373]    [Pg.4]   


SEARCH



Finland

© 2024 chempedia.info